FDA Adverse Event Injury Summary report: N

THERMOCOOL® SMARTTOUCH® SF BI-DIRECTIONAL NAV CATHETER

MDR report key: 6207900 · Received December 27, 2016

Doing adverse event research by hand?

The Research Assistant searches MAUDE for you, groups reports by failure mode, and cites every record.

Free to try · every answer cites its records

Report

Report Number
9673241-2016-00900
Event Type
Injury
Date Received
December 27, 2016
Date of Event
November 30, 2016
Report Date
November 30, 2016
Manufacturer
BIOSENSE WEBSTER, INC. (JUAREZ)
Product Code
LPB
UDI-DI
10846835010183
PMA / PMN Number
P030031
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION WAS PROVIDED ON THE EVENT ON JANUARY 4, 2017 STATING THAT THE IMPELLA WAS USED BEFORE THE EVENT TO MAP THE VENTRICULAR TACHYCARDIA AND BECAUSE THE PATIENT HAD A LOW EJECTION FRACTION. (B)(4).

Additional Manufacturer Narrative · 1

TIME AT THE SITE OF INJURY. IRRIGATED CATHETER FLOW WAS SET AT 8ML/MIN. PATIENT RECEIVED ANTICOAGULANT DURING THE PROCEDURE WITH ACTIVATED CLOTTING TIME MAINTAINED AT 300 SECONDS DURING ENDOCARDIAL ABLATION AND LOWER DURING EPICARDIAL ABLATION. THERE IS NO INFORMATION REGARDING SPI VALUE. THERMOCOOL SMARTTOUCH SF CATHETER WAS NOT IN CLOSE PROXIMITY TO ANOTHER CATHETER. THERMOCOOL SMARTTOUCH SF CATHETER WAS ZEROED AFTER THE INITIAL WARM-UP PHASE, POST-CONNECTION TO THE CARTO 3 PATIENT INTERFACE UNIT. CARTO 3 SYSTEM DID NOT INDICATE TO RE-ZERO THE CATHETER. THERE WERE NO ERROR MESSAGES REPORTED ON ANY BIOSENSE WEBSTER INC. EQUIPMENT DURING THE PROCEDURE. SINCE THIS ADVERSE EVENT REQUIRED MEDICAL OR SURGICAL INTERVENTION TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE, IT IS TO BE CONSIDERED SERIOUS AND MDR REPORTABLE. THE PRODUCT WAS DISCARDED, THEREFORE NO PRODUCT FAILURE ANALYSIS CAN BE CONDUCTED AND DEVICE MALFUNCTION CANNOT BE CONFIRMED. THE DEVICE HISTORY RECORD (DHR) FOR THE LOT NUMBER 17475289L HAS BEEN REVIEWED AND IT WAS VERIFIED THAT DEVICE WAS MANUFACTURED IN ACCORDANCE WITH DOCUMENTED SPECIFICATIONS AND PROCEDURES. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT A MALE PATIENT UNDERWENT AN EPICARDIAL ABLATION PROCEDURE FOR VENTRICULAR TACHYCARDIA WITH A THERMOCOOL SMARTTOUCH SF CATHETER AND SUFFERED A CARDIAC TAMPONADE (REQUIRING PERICARDIOCENTESIS) AND HEART FAILURE (REQUIRING A SURGICAL INTERVENTION: IMPELLA VENTRICULAR ASSIST DEVICE). AT THE END OF THE PROCEDURE, WHEN THE CATHETER WAS BEING REMOVED, BLOOD WAS OBSERVED IN THE SHEATH. BLOOD PRESSURE BECAME SLIGHTLY REDUCED. PERICARDIOCENTESIS YIELDED AN UNKNOWN AMOUNT OF FLUID. PATIENT WAS REPORTED TO BE IN STABLE CONDITION AT THE TIME OF COMPLAINT REPORT. PATIENT TRANSFERRED TO THE OPERATING ROOM FOR AN IMPELLA VENTRICULAR ASSIST DEVICE (VAD). PATIENT REQUIRED EXTENDED HOSPITALIZATION DUE TO HIS REDUCED RIGHT VENTRICULAR FUNCTION AND FOR RECOVERY FROM THE IMPELLA PLACEMENT. PATIENT OUTCOME WAS NOTED TO BE WORSENED, AS THE PATIENT REMAINS HOSPITALIZED. PATIENT FACTORS THAT MAY HAVE CONTRIBUTED TO THE ADVERSE EVENT INCLUDE THAT THE PATIENT HAD A LOW EJECTION FRACTION. PHYSICIAN¿S OPINION REGARDING THE CAUSE OF THE ADVERSE IS THAT IT WAS RELATED TO PROCEDURE, AS EPICARDIAL ABLATION INVOLVES RISK AND RELATED TO PATIENT CONDITION, AS THE PATIENT¿S CARDIAC HEALTH WAS COMPROMISED. TRANSSEPTAL PUNCTURE WAS PERFORMED WITH A ST. JUDE MEDICAL BROCKENBROUGH EXTRA SHARP (BRK-XS) TRANSSEPTAL NEEDLE. THERE IS NO SHEATH INFORMATION. GENERATOR PARAMETERS AT THE TIME OF INJURY INCLUDED: POWER CONTROL MODE AT 30 WATTS (NOT TITRATED) WITH DEFAULT TEMPERATURE CUT-OFF. OVERALL ABLATION TIME WAS APPROXIMATELY 20 MINUTES. THERE IS NO INFORMATION REGARDING LAST ABLATION CYCLE

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
855689 THERMOCOOL® SMARTTOUCH® SF BI-DIRECTIONAL NAV CATHETER CARDIAC ABLATION PERCUTANEOUS CATHETER LPB BIOSENSE WEBSTER, INC. (JUAREZ) D-1348-05-S 17475289L 10846835010183

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R